Medicine
| ISSN | 14248832, 14248840 |
|---|---|
| Country | Switzerland |
| Publisher | S. Karger AG |
| Subject Areas | Medicine |
| Publication Type | Journals |
| Active Years | 2002-2003, 2005-2010 |
| Competitiveness | 1. (0-20) Least Competitive |
| Publication Time | **N/A |
| Website | Visit journal |
The field of haemostasis and thrombosis has witnessed significant developments during the last few decades. While the upcoming of biochemistry, cell biology and later of molecular biology as new research tools has constantly been reflected in the journal, it nevertheless continues to devote many of its pages to traditional clinical pathophysiology. The journal features original contributions reporting the latest findings on the pathology, physiology and biochemistry of haemorrhagic disease and thrombosis as well as on their diagnosis and treatment. In addition to in-depth studies of such topics as blood coagulation factors, fibrinolysis, platelets and vascular biology, readers will find extensive data on clinical results with heparin.
| Year | 2-Year IF | 3-Year IF | 4-Year IF |
|---|---|---|---|
| 2012 | 0.875 | — | — |
| 2011 | 0.529 | — | — |
| 2010 | 0.915 | — | — |
| 2009 | 0.446 | — | — |
| 2008 | 1.990 | — | — |
| 2007 | 1.366 | — | — |
| 2006 | 0.667 | — | — |
| 2005 | 1.082 | — | — |
| 2004 | 0.944 | — | — |
| 2003 | 0.394 | — | — |
Note: impact factor data for reference only.
The H-Index measures both the productivity and citation impact of a journal's publications.
| Year | H-Index |
|---|---|
| 2021 | 52.000 |
| 2020 | 51.000 |